News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
The story of abiraterone
Abiraterone is one of the ICR’s biggest success stories: the first treatment shown to be effective in men with advanced prostate cancer. But it took almost 20-years of hard work to take the drug from an initial idea to the clinic, where it now transforms the lives of more than 25,000 patients every year.
Statement in response to NICE final draft guidance recommending enzalutamide for prostate cancer
The Institute of Cancer Research welcomes NICE draft guidance recommending patients with advanced prostate cancer who have had chemotherapy receive the life-extending drug on the NHS.
ICR supports petition on Royal Brompton redevelopment plans
Chelsea plans could threaten ICR operations, while loss of site to residential development would dash hopes for once-in-a-lifetime opportunity to strengthen ties with The Royal Marsden hospital.
Scientists find new exploitable weakness in cancer cells
Scientists have discovered a new way to target cancer cells and prevent them from dividing properly, causing them to die.
'Dustman' protein helps bin cancer cells
New findings suggest a test could identify patients who would be most responsive to a new class of cancer drugs and also those who might develop resistance.
485x364.jpg?sfvrsn=38a9d0b9_2 "DNA microarray (lowres)485x364")
First genetic link discovered to difficult-to-diagnose breast cancer sub-type
Scientists have identified the first genetic variant specifically associated with the risk of invasive lobular carcinoma, a difficult-to-diagnose cancer sub-type accounting for around 10-15% of all breast cancer cases.
MicroRNA could be key target for bowel cancer treatment
A tiny genetic molecule called microRNA plays a central role in bowel cancer and could be key to developing new treatments for the disease, say ICR Researchers.
Professor Alan Ashworth wins Genetics Society medal
Professor Alan Ashworth, Chief Executive of The Institute of Cancer Research, London, has been awarded the 2015 Genetics Society medal. The prestigious award is given annually for outstanding contributions to the study of genetics.
ICR professor is a 'Game Changer' in Woman’s Hour Power List
Professor Nazneen Rahman, head of the Division of Genetics and Epidemiology, has been announced as one of the top ten 'Game Changers' in the BBC Woman's Hour Power List of 2014.
ICR researcher wins award to present at top cancer conference
A young scientist at The Institute of Cancer Research, London, is presenting her work at a leading international cancer conference after winning a major award for early-career researchers.
Stopping cancer in its tracks: the ICR’s Discovery Club tackles cancer metastasis
Our latest Discovery Club event at the Royal Society gave members and guests an insight into a crucial area of our research: understanding how cancer cells spread around the body.
Video: Dr Chris Jones on the discovery of the genetic flaw that may hold the key to devastating childhood cancer
Dr Chris Jones tells Henry French about his team's discovery of a genetic flaw driving the deadly childhood brain cancer DIPG, its surprising links to a developmental syndrome in which muscle turns to bone, and how the discovery could lead to new therapies for this hard-to-treat cancer
